×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
Business Wire
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”),...
1 day ago
Innate Pharma Schedules Q1 2024 Business Update - TipRanks.com
Tipranks
Innate Pharma S.A. (FR:IPH) has released an update. Innate Pharma S.A., a clinical-stage biotechnology company, has scheduled a conference...
1 day ago
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
BioSpace
Drugmakers, including the genetic testing company 23andMe, are using novel approaches to stimulate NK cells' intrinsic ability to recognize...
2 weeks ago
Biotechnology - Rigel Pharmaceuticals, Innate Pharma
The Pharma Letter
The week in pharma: action, reaction and insight – week to August 5. 07-08-2022. Among M&A news last week, US biotech Amgen on Thursday announced it is to...
1 day ago
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
Yahoo Finance
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn't one of the 30 most popular stocks...
1 month ago
Innate Pharma plans IND of ADC candidate after positive preclinical data
Pharmaceutical Technology
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.
1 month ago
Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year
Simply Wall Street
Following the recent earnings report, the consensus from six analysts covering Innate Pharma is for revenues of €52.3m in 2024. This implies a...
1 month ago
The Globe and Mail
The Globe and Mail
DelveInsight's, “NK Cell Therapy Pipeline Insight 2024” report provides comprehensive insights about 100+ companies and 185+ pipeline drugs...
18 hours ago
Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to ...
Business Wire
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the first patient was...
3 weeks ago
Sanofi licenses fourth NK cell engager from Innate Pharma
Pharmaceutical Technology
Sanofi licenses fourth NK cell engager from Innate Pharma. Sanofi and Innate's cancer collaboration agreement stretches back to 2016, with two...
4 months ago